Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment

Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment

Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

The Patient-Centered Outcomes Research Institute (PCORI) is an independent, nonprofit research organization that seeks to empower patients and others with actionable information about their health and healthcare choices. We fund comparative clinical effectiveness research (CER), which compares two or more medical treatments, services, or health practices to help patients and other stakeholders make better informed decisions.

PCORI’s unique place in the health research landscape stems from its unwavering focus on outcomes that matter to patients and it is widely acknowledged as a leader in driving US clinical research to become more patient-centered. We are committed to ensuring that patients and other healthcare stakeholders have a seat at the table throughout the research process—helping to prioritize research topics, design and conduct the studies, and share the results.

The vast majority of the research that PCORI funds is for CER projects, but we also fund awards to promote engagement in research, dissemination and implementation projects, methodology research, and the development of research infrastructure, including PCORnet®, the National Patient-Centered Clinical Research Network. We issue PCORI Funding Announcements several times each year.

Founded in 2005 AMPS, a recognized leader in healthcare cost containment, is a comprehensive cost containment company that addresses all aspects of an employer’s healthcare spend from medical and prescription, to stop loss and administrative healthcare services. Our goal: to lower medical and prescription costs with minimal overall disruption, while providing our clients with a customized, turn-key solution that meets them exactly where they are.

Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world. For more information on Astellas, please visit: https://www.astellas.com/us You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma-us

AffirmedRx is on a mission to improve health care outcomes by bringing clarity, integrity and trust to pharmacy benefit management. Our approach allows us to put members and our clients first, which directly supports the goals of our clients and the consultants and brokers searching for the best solution. Our differentiators below outline how we believe we are fundamentally different: 1. AffirmedRx, a Public Benefit Corporation or PBC 2. By Employers, For Employers 3. Personalized care and compassionate navigation 4. The model that matters: Patients over Profits 6. Intuitive, hyperflexible technology and an intelligent, care-driven platform

Famlee provides employers an affordable step-therapy fertility treatment options before going directly to IVF. With other conditions, the status quo isn't to jump from a medical condition to the most costly intervention available. Yet, with fertility benefits, this is often the norm. Famlee takes a conservative care approach to fertility support and treatment. Famlee is an affordable, step-therapy fertility treatment solution that combines at-home labs with fertility telehealth and prescription delivery, all from the comfort of home - with the goal to avoid IVF. . Combining innovative technology with compassionate care—backed by a commitment to personalized, evidence-based solutions—Famlee helps women improve ovulation and identify and treat critical hormonal imbalances impacting fertility. Despite the rising costs of fertility services, employers are saving hundreds of thousands of dollars, if not more, by utilizing Famlee's innovative step-therapy treatment approach before IVF. Women deserve better, and employers deserve affordable options—Famlee delivers both.

Galileo is a Multispecialty Digital Medical Practice with a full-time team of PCPs and Board Certified Specialists. We provide urgent, primary, complex, chronic, and behavioral healthcare through a single app-based solution. Our delivery model includes built-in second opinion, navigation and advocacy for a coordinated care experience. We go beyond legacy telemedicine to improve member experience, lower cost of care and improve outcomes for the entire family.
Value Proposition
Galileo goes beyond legacy telemedicine, creating a new delivery model that improves member experience, lowers the cost of care and achieves better health outcomes.
• Provider quality: We only employ dedicated, full-time clinicians with a minimum of 10 years’ experience and a background in virtual care.
• Breadth of multispecialty care: Our team-based approach to care delivers faster, peer-reviewed diagnosis and treatment. We have the ability to treat diverse populations and manage chronic diseases over time.
• Technology: Our proprietary EMR is designed for longitudinal care and gives providers data and insights at the point of care to practice better medicine.
• Unified solution: Galileo’s team-based approach includes fully integrated behavioral health, built-in second opinion, care navigation and advocacy. We work within benefit ecosystems — ensuring referrals to preferred networks, labs, pharmacies and existing point solutions to drive the highest value.

Hello Heart is the only digital therapeutics company to focus exclusively on heart disease, the leading cause of death worldwide. Through a connected mobile device that uses AI, behavioral science, and personalized digital coaching to drive lifestyle changes, Hello Heart empowers people to reduce blood pressure and predicts serious heart issues before they occur. Validated in peer-reviewed studies, Hello Heart is easy to use and works alongside an employer’s benefits ecosystem. Leading employers across most major industries are realizing immediate and sustained results for member engagement, clinical outcomes, and reduced cost of unnecessary cardiac procedures. Founded in 2013, Hello Heart is a member of the American Heart Association’s Innovators’ Network and is part of the CVS Health Point Solutions Management Program. Visit www.helloheart.com for more information.

Ochsner Health has been providing high-quality clinical and hospital patient care to the people of Louisiana, Mississippi and the Gulf South since 1942. Our healthcare family—today, comprising more than 30,000 employees and over 4,500 providers in over 90 medical specialties and subspecialties—is driven by our commitment to our mission to Serve, Heal, Lead, Educate and Innovate, and that passion is shared with every person who passes through our doors.
Ochsner's Digital Medicine solution provides one-on-one, personalized care to manage a member's high blood pressure or Type 2 diabetes without having to make multiple trips to the doctor. Real-time data is shared with the member's personal Digital Medicine care team, who monitors their readings and results to help make treatment decisions. The inclusion of a licensed clinician to manage medications allows for true management of the member’s condition rather than simply monitoring.

Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. are the US-based indirect subsidiaries of the global healthcare company Otsuka Pharmaceutical Co. Ltd with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka’s US companies share a deep commitment to the development and commercialization of innovative products in the spaces of neuroscience, nephrology, and digital medicine.

We have an unwavering belief in doing more and going above and beyond — under any circumstances- so that patients can push past the limitations of their disease and achieve more than they thought was possible every day.

At Otsuka, we hold a deep respect for the value of every mind. We believe that the human mind is infinitely valuable, fostering imagination, intelligence, perception, and so much more. By recognizing this value, we have the power to change the trajectory of people’s lives. This is why we will not rest until mental illness is approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention. Through products, programs, policies, and advocacy, Otsuka-people will defy any limitation that stands in their way until every mind is valued. Discover our commitment to health for every mind: Valued Minds | Otsuka US (otsuka-us.com)

Known as the silent killer, chronic kidney disease (CKD) hides within a population often until the disease is advanced and results in emergent dialysis treatment. Health plans need dynamic and effective resources to protect their members and plan assets before it’s too late, and they are faced with unexpected or increased costs, an overall poor workforce health, or even death.

We provide the most comprehensive CKD risk management and dialysis cost-containment methodology to improve plan member health and protect plan assets.

Vida is a virtual care company that combines a human-centric approach with technology to treat cardiometabolic conditions, like diabetes and obesity, with their underlying mental health symptoms. Our platform deeply integrates individual, expert care with machine learning and remote monitoring to deliver lasting behavior change, health outcomes, and cost savings for your organization and its people. Vida is the only virtual care company to put 100% of fees at risk. Please reach out if you want to discuss how Vida can give your members immediate access to better cardiometabolic healthcare for lasting outcomes and real cost savings.

VIVIO Health VIVIO, A Public Benefit Corporation, eliminates low-value care by identifying expensive specialty drug therapies that don’t work even with FDA approval; not knowing patients’ drug responses; doctors not reading clinical trials; the arbitrary line between pharmacy drugs and medical benefits; and egregious supply chain waste. We use clinical trials and other clinical evidence to personalize drug therapies for every member that we serve, resulting in better health outcomes that cost less.

WellSpark delivers whole-person wellbeing support. From group and individual lifestyle coaching and chronic disease management, to incentive programs, we have everything employers need to cultivate and promote a culture of wellbeing. And since no individual – or company – is the same, we specialize in not being one-size-fits all. Clients have options to build the digital experience that makes the most sense for their employees, using it as the entry point to access live coaches and group programs, all focused on topics that are meaningful and culturally relevant. Employees face numerous challenges—physical, psychological, and social—that can become barriers to maintaining good health. We take the time to make connections between health, data, work, and personal experiences; then meet people where they are with actions that are compatible to their unique individual circumstances. This life-dimensional approach is what makes WellSpark different.